Is Genentech losing its zest for innovation? Genentech has long been known for innovation, but that reputation has been questioned in the wake of multiple rounds of layoffs and the company’s ...

On Genentech's website, the company notes that its large South San Francisco campus encompasses scientific research, manufacturing and “various business functions.” Earlier this month ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...

Genentech has received Food and Drug Administration approval for its treatment of certain types of lung, liver, skin and soft tissue cancer in adults. The treatment, called Tecentriq Hybreza, can ...

Genentech, a drugmaker based in South San Francisco, is laying off 93 more local workers just months after a 436-worker cut. The company, which is owned by Swiss pharmaceutical giant Roche ...

September 12, 2024--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq ...

(KRON) — Biotech firm Genentech is laying off nearly 100 employees at its South San Francisco headquarters, according to a WARN notice from the California Employment Development Department (EDD).

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...